期刊文献+

脑囊虫病患者血清循环抗原、IgG4与神经影像学关系研究 被引量:2

Relationship of Serum Circulating Antigen and Specific IgG4 with Neuroimaging in Patients with Neurocysticercosis
下载PDF
导出
摘要 目的探讨脑囊虫病血清循环抗原(CAg)、特异性IgG4与神经影像学(CT、MRI)的关系。方法对根据DelBrutto等于2001年提出的诊断脑囊虫病的四个标准确诊的36例脑囊虫病患者分别行CAg定量测定、IgG4定性测定及神经影像学检查。结果按照神经影像学变化,脑囊虫可分为活虫期、变性死亡早期、变性死亡后期及钙化期,其各期之间的患者血清CAg水平有显著差异(P<0.05)。血清中CAg的含量及血清特异性IgG4阳性强度与脑囊虫病的神经影像学分期呈显著正相关(r=0.871,0.602,P<0.01)。结论①脑囊虫病人血清CAg、IgG4水平与神经影像学(CT、MRI)表现具有相关性;②血清CAg和特异性IgG4的检查可用于脑囊虫病的早期诊断和指导其临床治疗。 Objective To investigate the relationship of serum circulating antigen (CAg) and specific IgG4 with neuroimaging in the patients with neurocystieereosis. Methods According to the four standards to diagnose neurocysticereosis which were introduced by Del Brutto et al in 2001, neurocysticercosis were definitely diagnosed as in 36 patients, in whom the quantitative assay of serum CAg, qualitative test of serum specific IgG4 and neuroimaging examination were performed. Results There were significantly differences in serum CAg and IgG4 contents among active stage, early degeneration stage, later degeneration stage, and calcic stage determined by the neuroimaging examination (P〈0.01). The serum CAg content and the specific IgG4 intensity were significantly related with the stage of the neuroimaging of the neurocysticercosis (r=0.871 and 0.602 respectively, P〈0.01). Conclusions (1) The serum CAg and IgG4 are related to the stage of the neuroimaging in the patients with neurocysticercosis. (2) Testing of serum CAg and specific IgG4 may be used for the early diagnosis and guiding the clinical treatment of the neurocysticercosis.
出处 《中国临床神经外科杂志》 2009年第9期523-526,共4页 Chinese Journal of Clinical Neurosurgery
关键词 脑囊虫 循环抗原 IGG4 神经影像学(CT、MRI) Neurocysticercosis Circulating antigen IgG4 Neuroimaging(CT, MRI)
  • 相关文献

参考文献9

  • 1Garcia HH, Evans CA, Nash TE, et al . Current consensus guidelines for treatment of neurocysticercosis [J]. Clin Microbiol Rev, 2002, 15: 747-756.
  • 2Garcia HH, Gonzalez AE, Evans CA, et al. Taenia solium cysticercosis [J]. Lancet, 2003, 362(9383): 547-556.
  • 3Sciutto E, Fragoso G, Fleury A. Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions [J]. Microbes Infec, 2000, 2:1875-1890.
  • 4Del Brutto OH, Rajshekhar V, White AC, et al. Proposed diagnostic criteria for neurocysticercosis [J]. Neurology, 2001, 57(2): 177-183.
  • 5Raul JB, Marisela H, Carlos M, et al. Subarachnoidal and intraventricular human neurocysticercosis:application of an antigen detection assay for the diagnosis and follow-up [J]. Trop Med Int Health, 2006, 11(6): 943-950.
  • 6Erhart A, Dorny P, De NV, et al. Taenia solium cysticercosis in village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen [J]. Trans Royal Soci Trop Medi Hyg, 2002, 96: 270-272.
  • 7Ensenat J, Martinez-Manas R, Horcajada JP, et al . Diagnostic and therapeutic difficulties in neurocysticereosis: presentation of 6 cases and review of the literature [J]. Neurocirugia (Astur), 2007, 18(2): 101-110.
  • 8Nguekam, Zoli AP, Ongolo-Zogo P, et al . Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA [J]. Parasite, 2003, 10: 65-68.
  • 9Huang BC, Li GP, Jia FJ, et al . Determination of specific IgG4 for diagnosis and therapeutic evaluation of cerebral cysticercosis [J]. Chin Med J 2002, 115(4): 580-583.

同被引文献19

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部